MPM Capital definition

MPM Capital means, collectively, MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM BioVentures III Parallel Fund, L.P., MPM Asset Management Investors 2005 BVIII LLC, MPM BioEquities Master Fund LP and their respective Affiliates.
View Source
MPM Capital means MPM Asset Management LLC, a limited liability company organized under the laws of Delaware.
View Source

Examples of MPM Capital in a sentence

  • MPM Capital shall have the right to elect one (1) director who shall be an individual with particular expertise in the development of pharmaceutical products (the “Industry Expert Director”) and who initially shall be ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇.

  • The Company shall have raised at least $40,000,000 from the Investors pursuant to this Agreement; provided, however, that, notwithstanding Section 10.2, this condition may be waived solely by MPM Capital.

  • The initial press release with respect to the execution of this Agreement shall be approved by the Company and MPM Capital on behalf of the Investors.

  • Its investors include partners and affiliates of ▇▇ ▇▇▇▇▇▇, BB Biotech, MPM Capital, Alta Partners, ▇▇▇▇▇▇▇▇ Ventures, Life Sciences and International BioTechnology Trust plc, and ▇▇▇▇▇▇▇ ▇▇▇▇▇ KECALP.

  • On or prior to the Initial Closing, existing Management Rights Letters between the Company and each of (i) WCAS and its affiliates, (ii) MPM Capital and its affiliates, (iii) Pitango Venture Capital and its affiliates and (iv) ONSET VI, L.P., shall have been amended and restated and delivered to the applicable Investor, in each case, in a form satisfactory to WCAS.

  • Director c/o MPM Capital L.P. Office of Technology Development The ▇▇▇▇ ▇▇▇▇▇▇▇ Tower CB #4105, ▇▇▇ ▇▇▇▇▇ ▇▇▇▇ 200 Clarendon Street UNC-CH ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ With a copy to: WilmerHale LLP ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇ ▇.

  • The Series A financing was led by MPM Capital, with participation from Aeris Capital, and Affimed AG.

  • MPM Capital is one of the world’s largest life science-dedicated venture investors.

  • With committed capital under management in excess of $2.6 billion, MPM Capital is uniquely structured to invest globally in healthcare innovation.

  • Kazumi Shiosaki, Ph.D., representing MPM Capital, shall have been appoin▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇any's drug development committee (or similar committee as appropriate) to serve until a senior executive officer in the area of drug development, which individual shall have extensive small molecule experience and expertise, has been appointed by the Board of Directors.